NeuMoDx EBV Quant Assay 2.0

Epstein-Barr virus DNA quantification assay · QIAGEN Gaithersburg, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NeuMoDx EBV Quant Assay 2.0, covering 2024-11-08 to 2024-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant Patients